Interestingly, while TGF-β1 expression is decreased by a TLR2 agonist in patients with CRSwNP, it is increased by a TLR4 agonist in patients with CRSsNP; MMP-9 is also upregulated in such cases [96]. The gene discussed is TLR2; the disease is chronic rhinosinusitis with nasal polyps.